Sg Americas Securities, LLC Seelos Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 13, 2023	SELL	$0.16 - $1.64 $696 - $7,135	-4,351 Reduced 13.11%	28,845 $5,000
Q2 2023 Jul 10, 2023	SELL	$0.66 - $1.22 $2,888 - $5,339	-4,377 Reduced 11.65%	33,196 $40,000
Q1 2023 Apr 28, 2023	SELL	$0.59 - $1.04 $4,488 - $7,911	-7,607 Reduced 16.84%	37,573 $26,000
Q4 2022 Feb 02, 2023	SELL	$0.66 - $259.46 $5,881 - $2.31 Million	-8,912 Reduced 16.48%	45,180 $31,000
Q3 2022 Oct 31, 2022	BUY	$0.65 - $278.68 $35,159 - $15.1 Million	54,092 New	54,092 $56,000
Q1 2022 Apr 29, 2022	SELL	$0.84 - $1.71 $10,067 - $20,494	-11,985 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$1.59 - $2.38 $34,337 - $51,398	-21,596 Reduced 64.31%	11,985 $20,000
Q3 2021 Nov 01, 2021	BUY	$1.69 - $2.89 $23,377 - $39,977	13,833 Added 70.05%	33,581 $81,000
Q2 2021 Aug 12, 2021	BUY	$2.64 - $6.32 $52,134 - $124,807	19,748 New	19,748 $52,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $117M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.